pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,973 catalysts · 4,970 phase readout · 2,360 8k filing · 287 earnings · 278 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 31 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,360
  • earnings287
  • pdufa278
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07366294: Lemongrass (Cymbopogon Citratus) on Nicotine Dependence, Cotinine Levels, and Related Biomarkers in Adult Smokers

    Sponsor: Titin Andri Wihastuti. Phase: NA. Conditions: Nicotine Dependence, Cigarette Smoking, Tobacco Use Disorder, Psychological Stress, Sleep Disturbance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07381894: Multicentre Hypertrophic Cardiomyopathy Registry

    Sponsor: University of Manchester. Phase: . Conditions: Hypertrophic Cardiomyopathy (HCM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06738966: A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer

    Sponsor: Shanghai Best-Link Bioscience, LLC. Phase: PHASE1. Conditions: Breast Cancer, Ovarian Cancer, Endometrial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07070466: Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Stomach Cancer Stage IV, Esophagus Cancer, Stomach Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05977556: Perioperative Prehabilitation on Markers of Fitness and Frailty in Patients Undergoing Elective Surgery

    Sponsor: University of Alberta. Phase: PHASE1. Conditions: Frailty

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03776656: Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Adenylosuccinate Lyase Deficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05925322: Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

    Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Depression, Suicidal Ideation, Major Depressive Disorder, Depressive Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05399329: Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

    Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05934929: Contribution of Residual Tumour DNA Testing on the Surgical Bed

    Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Squamous Cell Carcinoma of the Oral Cavity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06426329: The Effect of Therapeutic Touch at Birth on Pain, Birth Duration, Traumatic Birth Perception and Anxiety

    Sponsor: Cumhuriyet University. Phase: NA. Conditions: Pregnancy, Vaginal Delivery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06141031: Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

    Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Pancreatic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06789653: A Novel Approach Utilizing Organ Specific Age Proteomics

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07564297: North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

    Sponsor: Mayo Clinic. Phase: . Conditions: Congenital Diaphragmatic Hernia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06993610: Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

    Sponsor: Zura Bio Inc. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07436182: Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy

    Sponsor: Mansoura University. Phase: PHASE4. Conditions: Mitochondria, Metformin

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07437482: Cancer Literacy Education and Awareness Resources for Prostate Care

    Sponsor: Universidad Miguel Hernandez de Elche. Phase: . Conditions: Health Literacy, Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04899024: PrEP Affect Regulation Treatment Innovation

    Sponsor: Florida International University. Phase: NA. Conditions: Medication Adherence, HIV Prevention, Stimulant Use

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07554924: A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

    Sponsor: Lanyue Biotech (Hangzhou) Co., Ltd.. Phase: PHASE1. Conditions: Spinal Muscular Atrophy 1

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07560124: A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer

    Sponsor: Akeso. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07136688: Tibial Nerve Stimulation for Pediatric Spina Bifida Neurogenic Bladder

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Neurogenic Bladder Due to Spina Bifida

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07566442: Frenkel Exercises on Balance and Quality of Life Post Burns

    Sponsor: Cairo University. Phase: NA. Conditions: Burns, Lower Limb Burn Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06597942: Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)

    Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease, Dementia Alzheimer Type, Mild Alzheimer&Amp;Amp;#39;s Disease, Moderate Alzheimer&Amp;Amp;#39;s Disease, Alzheimer&Amp;#39;s Disease (AD), Alzheimer&Amp;#39;s Dementia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07561242: Clinical Observational Study on Changes in Skin Physiological Parameters Following Ablative and Non-Ablative Fractional Laser Treatment at Different Doses

    Sponsor: ChinaNorm. Phase: . Conditions: Skin Barrier Function, Wound Healing

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06124586: Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

    Sponsor: Heinrich-Heine University, Duesseldorf. Phase: NA. Conditions: Diabetic Foot, Diabetes Mellitus, Peripheral Arterial Disease, Diabetic Neuropathies, Diabetic Retinopathy, Anemia, Ulcer Foot, Ulcer Ischemic, Diabetic Polyneuropathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05297786: Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Hemodialysis Complication, Hypotension of Hemodialysis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07340073: Coordinated Reset Deep Brain Stimulation for Parkinson's Disease

    Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Parkinson's Disease (PD), Deep Brain Stimulation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06396741: Changes in the Quadriceps Muscle After Dry Needling Treatment

    Sponsor: Prof. Dr. Daniel Pecos Martín. Phase: NA. Conditions: Muscle Tightness, Muscle Strain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07220954: A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07479654: AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease

    Sponsor: Mackay Memorial Hospital. Phase: NA. Conditions: Adult Congenital Heart Disease, Symptom Clusters, Frailty, Risk Prediction Model, Artificial Intelligence-Based Voice Emotion Detection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06866405: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

    Sponsor: Pfizer. Phase: PHASE3. Conditions: RSV Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06730594: A Study to Assess the Effect of the Bio-K+ Probiotic Capsules (VL-BK-02) in Adults With Functional Constipation

    Sponsor: Vedic Lifesciences Pvt. Ltd.. Phase: NA. Conditions: Functional Constipation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07371741: PICS Clinic Attendance and Recovery Engagement (PICS-CARE)

    Sponsor: Charite University, Berlin, Germany. Phase: . Conditions: Post-intensive Care Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05822466: Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults

    Sponsor: Oregon Research Institute. Phase: NA. Conditions: Accidental Fall

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06160466: Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in Follow-up Patients in a Screening Setting

    Sponsor: Fondazione Poliambulanza Istituto Ospedaliero. Phase: NA. Conditions: Colonic Adenoma, Adenoma, Polyp of Colon

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06700356: Thalamus Seizure Detection With a Deep Brain Stimulator System

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Epilepsy; Seizure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07441356: Female Trauma Cases

    Sponsor: Assiut University. Phase: . Conditions: Violence Against Women (VAW)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07460856: Effects of Cranberry on Gut and Metabolic Health

    Sponsor: Laval University. Phase: NA. Conditions: Overweight/Obesity, Metabolic Syndrome, Insulin Resistance, Microbiota

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07464756: SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Gastric Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06576622: PERIodontal Disease, Microbiota and Miscarriage

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Miscarriage, Parodontitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06438562: Evaluation of Vitamin A Absorption From Fortified Bouillon

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Healthy Volunteers, Vitamin A

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07251803: GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound

    Sponsor: Medical University of South Carolina. Phase: . Conditions: Gastric Retention

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07416903: NT-Based Group Psychoeducation for Parents of Autistic Preschoolers in Türkiye

    Sponsor: Kocaeli University. Phase: NA. Conditions: Autism Spectrum Disorder, Parenting Self-efficacy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05005403: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Micro Satellite Stable Colorectal Cancer, Gastric/Esophageal Cancer, High-Grade Serous Ovarian Cancer, Pancreatic Cancer, Triple Negative Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03872427: Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor, Unresectable Malignant Solid Neoplasm

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07367061: Clinical Investigation to Assess Safety and Efficacy of INNEA AQUA in Adult Women With Vulvo-Vaginal Atrophy (VVA)

    Sponsor: Innate srl. Phase: NA. Conditions: Vulvo Vaginal Atrophy

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05042661: Acupuncture-like Transcutaneous Electrical Nerve Stimulation on Bowel Symptom and Quality of Life in Patients With Irritable Bowel Syndrome

    Sponsor: National Taipei University of Nursing and Health Sciences. Phase: NA. Conditions: Acupuncture-like Transcutaneous Electrical Nerve Stimulation, Irritable Bowel Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05665361: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07559786: A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

    Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: SCLC, Limited Stage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03849586: Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

    Sponsor: European Association of Urology Research Foundation. Phase: . Conditions: Erectile Dysfunction

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05691270: Contraception Navigator Program

    Sponsor: Indiana University. Phase: NA. Conditions: Contraception, Contraceptive Usage, Health Care Utilization

    full page →ctgov ↗
    ← prev
    page 26 of 100
    next →